Lv1
38 积分 2025-08-13 加入
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
25天前
已完结
Farnesylation-driven KRAS phase separation promotes colon tumor growth
1个月前
已完结
Targeting ATP7A-Dependent Copper Metabolic Homeostasis Induces Cuproptosis and Suppresses the Progression of Mutant KRAS-Driven Lung Cancer
2个月前
已完结
RNF217-KEAP1-NRF2 feedback loop confers therapeutic resistance by inhibiting ferroptosis in esophageal squamous cell carcinoma
2个月前
已完结
KRAS-driven protein disulfide isomerase family A member 6 expression suppresses PRKR-like endoplasmic reticulum kinase-mediated immunogenic cell death to desensitise pancreatic ductal adenocarcinoma to immune checkpoint blockers
3个月前
已完结
Direct sensing of dietary ω-6 linoleic acid through FABP5-mTORC1 signaling
4个月前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
5个月前
已完结
Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancer
7个月前
已完结
皖公网安备34019202002308
